Johnson & Johnson Aktie 943981 / US4781601046
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
13.12.2025 02:55:14
|
FDA Approves Johnson & Johnson's AKEEGA For BRCA2-Mutated Prostate Cancer
(RTTNews) - Johnson & Johnson (JNJ) announced that the U.S. Food and Drug Administration has approved its supplemental New Drug Application (sNDA) for AKEEGA—a dual-action tablet combining niraparib and abiraterone acetate—administered with prednisone. This new treatment is indicated for patients with BRCA2-mutated metastatic castration-sensitive prostate cancer (mCSPC).
BRCA mutations are associated with more aggressive forms of prostate cancer and poorer outcomes. The approval of AKEEGA addresses a critical unmet need, offering a new therapeutic option for patients who previously had limited treatment alternatives.
In April 2016, Janssen Biotech Inc. entered a worldwide (except Japan) collaboration and license agreement with TESARO, Inc. (acquired by GlaxoSmithKline in 2019) for exclusive rights to niraparib in prostate cancer.
For More Such Health News, visit rttnews.com.
Nachrichten zu Johnson & Johnson
|
15.12.25 |
Dow Jones-Handel aktuell: Dow Jones legt zum Handelsende den Rückwärtsgang ein (finanzen.ch) | |
|
15.12.25 |
Johnson Johnson Aktie News: Johnson Johnson reagiert am Montagabend positiv (finanzen.ch) | |
|
15.12.25 |
Montagshandel in New York: Dow Jones zeigt sich nachmittags leichter (finanzen.ch) | |
|
15.12.25 |
Schwacher Wochentag in New York: Dow Jones präsentiert sich mittags schwächer (finanzen.ch) | |
|
15.12.25 |
Johnson Johnson Aktie News: Johnson Johnson am Montagnachmittag mit Aufschlag (finanzen.ch) | |
|
10.12.25 |
Dow Jones aktuell: Dow Jones verbucht zum Handelsende Zuschläge (finanzen.ch) | |
|
10.12.25 |
Handel in New York: Das macht der Dow Jones am Nachmittag (finanzen.ch) | |
|
10.12.25 |
Freundlicher Handel: Dow Jones-Börsianer greifen am Mittag zu (finanzen.ch) |